Literature DB >> 9472893

Randomized comparison of Guglielmi detachable coils and cellulose acetate polymer for treatment of aneurysms in dogs.

R L Macdonald1, S Mojtahedi, L Johns, A Kowalczuk.   

Abstract

BACKGROUND AND
PURPOSE: Endovascular treatments for aneurysms are being used more frequently in patients in the absence of a large body of information on their histopathological effects. This study determined the efficacy and histopathological effects of treatment of experimental aneurysms with Guglielmi detachable coils (GDC) or cellulose acetate polymer (CAP).
METHODS: Fourteen dogs had 13 terminal and 30 sidewall aneurysms created with venous pouches sutured to the cervical carotid arteries. Two weeks later, dogs had angiography followed by randomization to no treatment (n=2) or to aneurysm occlusion with GDC (n=4) or CAP (n=6). Two months later, angiography was repeated, animals were killed, and aneurysms were excised, fixed, photographed, and examined by light and electron microscopy.
RESULTS: Two dogs were excluded because of common carotid artery occlusion at 2-week angiography. There were 11 terminal and 16 sidewall aneurysms available for treatment. The rate of spontaneous thrombosis of untreated aneurysms was 0% (0/5). Treatment with GDC showed complete terminal and sidewall aneurysm obliteration rates of 33% (1/3) and 80% (4/5), respectively. Greater than 90% occlusion occurred in the remaining cases. There were no parent or branch artery occlusions. Treatment with CAP showed complete terminal and sidewall aneurysm obliteration rates of 20% (1/5) and 0% (0/5), respectively, and incomplete sidewall aneurysm obliteration in 1 of 5 cases. Aneurysms reformed at 2 months in 2 of 5 terminal and 1 of 5 sidewall cases. There were parent or branch artery occlusions with CAP in 2 and 4 cases, respectively. The rate of aneurysm occlusion was significantly lower and the rate of arterial occlusion significantly higher with CAP than with GDC (P<.05). Histopathology showed complete endothelialization across the orifice of the aneurysm successfully treated with CAP, whereas aneurysms treated with GDC were significantly more likely to show fresh or organizing thrombus without complete endothelialization (P<.05).
CONCLUSIONS: It is concluded that both treatments have limitations. Complete packing of aneurysms with GDC obliterates the aneurysm, but endothelialization does not always occur within 2 months. There are substantial problems with CAP. It is thrombogenic and carries a higher risk of causing arterial thrombosis. Even if an aneurysm is successfully obliterated initially with CAP, the CAP may disappear, leaving the aneurysm completely untreated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472893     DOI: 10.1161/01.str.29.2.478

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  A novel murine elastase saccular aneurysm model for studying bone marrow progenitor-derived cell-mediated processes in aneurysm formation.

Authors:  Brian L Hoh; Gregory J Velat; Erin N Wilmer; Koji Hosaka; Robert C Fisher; Edward W Scott
Journal:  Neurosurgery       Date:  2010-03       Impact factor: 4.654

Review 2.  Current diagnostic approaches to subarachnoid haemorrhage.

Authors:  Jean Marie U-King-Im; Brendan Koo; Rikin A Trivedi; Nicholas J Higgins; Keng Y Tay; Justin J Cross; Nagui M Antoun; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2005-02-12       Impact factor: 5.315

Review 3.  In vivo experimental intracranial aneurysm models: a systematic review.

Authors:  F Bouzeghrane; O Naggara; D F Kallmes; A Berenstein; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

4.  Videographic assessment of the embolic characteristics of three polymeric compounds: ethylene vinyl alcohol, cellulose acetate, and liquid urethane.

Authors:  A M Norbash; R J Singer
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

5.  Does endoluminal coil embolization cause distension of intracranial aneurysms?

Authors:  Simon C H Yu; Wilbur C K Wong; Albert C S Chung; Kwok-Tung Lee; George K C Wong; Wai S Poon
Journal:  Neuroradiology       Date:  2006-06-29       Impact factor: 2.804

6.  Cyanoacrylate embolization of experimental aneurysms.

Authors:  Jean Raymond; France Berthelet; Anne-Cécile Desfaits; Igor Salazkin; Daniel Roy
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

7.  An experimental aneurysm model: a training model for neurointerventionalists.

Authors:  I Q Grunwald; B Romeike; R Eymann; C Roth; T Struffert; W Reith
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

8.  Endovascular treatment of experimental cerebral aneurysms using thermoreversible liquid embolic agents.

Authors:  H Takao; Y Murayama; T Saguchi; T Ishibashi; M Ebara; K Irie; H Yoshioka; Y Mori; S Ohtsubo; F Viñuela; T Abe
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

9.  Histological findings in ruptured aneurysms treated with GDCs: six examples at varying times after treatment.

Authors:  Christoph Groden; Christian Hagel; Guenter Delling; Hermann Zeumer
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

10.  Alginate for endovascular treatment of aneurysms and local growth factor delivery.

Authors:  Jean Raymond; Annick Metcalfe; Anne-Cecile Desfaits; Edith Ribourtout; Igor Salazkin; Kevin Gilmartin; Gill Embry; Robert J Boock
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.